EchoNous, the Seattle-based medical tool provider, recently received FDA clearance for the its ultrasound-based tool designed for nurses to improve peripheral IV (PIV) catheter placements.
A new healthcare startup, New York City-based Medmo, has launched a platform that allows patients to name their own price for various imaging services, including MRIs and CT scans.
Healthcare M&A has been heating up for years, but sky-high valuations and rising competition may be causing some private equity buyers to walk away from the table.
Men, those with a comfortable social life and smokers trying to quit tobacco are among populations most likely to participate in lung cancer screening programs, according to a French report published in Clinical Lung Cancer this summer.
The FDA has approved the third generation of the MitraClip, which treats mitral regurgitation without open-heart surgery, device manufacturer Abbott announced July 12.
Gene editing can sound like the stuff of science fiction, but a new technique may allow scientists to remove harmful genes from white blood cells and replace them with more beneficial material. The development carries the potential to open new avenues to treat conditions from HIV and lupus to cancer.
Delaware's cancer mortality rate decreased 12 percent from 2010 to 2014 due to state-wide screening efforts and early detection, according to a new Division of Public Health (DPH) report. The state's rate still remains below the 14 percent national average.
Researchers from the University of Newcastle in Australia found that radiographers and patients generally agree on in-person risk communication about medical imaging examinations with ionizing radiation, according to research published in the August issue of Radiography.
Multiparametric MRI can provide value by highlighting changes in the prostate following MRI-guided focal laser ablation (FLA), according to a new study published by the American Journal of Roentgenology.
